Synthesis and cytostatic properties of structure-simplified analogs of dolastatin 15

Journal of Peptide Research

Volumn 54, Issue 6, 1999, Pages 460-467

  Hu, Ming Kuan ^a   Huang, W S ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Cancer therapies; Dolastatin 15; Drug screening program; Sulforhodamine B assay; Synthetic analogs

Indexed keywords

ANTINEOPLASTIC AGENT; CEMADOTIN; DOLASTATIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; OLIGOPEPTIDES; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; TUMOR CELLS, CULTURED;

AURICULARIA; DOLABELLA AURICULARIA;

EID: 0032759955     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.1999.00130.x     Document Type: Article

References (13)

1. Flam, F. (1994) The seas for promising drugs. Science 266, 1324-1325.
2. Pettit, G.R., Kamano, Y., Herald, C.L., Fujii, Y., Kizu, H., Boyd, M.R., Boettmer, F.E., Doubek, D.L., Schmidt, J.M. & Chapuis, J.-C. (1993) Isolation of dolastatins 10-15 from the marine mollusk Dolabella auricularia. Tetrahedron 49, 9151-9170.
3. Roux, F., Galéotti, N., Poncet, J., Jouin, P., Cros, S. & Zenke, G. (1994) Synthesis and in vitro cytotoxicity of diastereoisomerically modified dolastatin 15 analogs. Bioorg. Med. Chem. Lett. 4, 1947-1950.
4. De Arruda, M., Cocchiaro, C.A., Nelson, C.M., Crinnel, C.M., Janssen, B., Haupt, A. & Barlozzari, T. (1995) LU 103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis. Cancer Res. 55, 3085-3092.
5. Pettit, G.R., Flahive, E.J., Boyd, M.R., Bai, R., Hamel, E., Pettit, R.K. & Schmidt, J.M. (1998) Antineoplastic agents 360. Synthesis and cancer cell growth inhibitory studies of dolastatin 15 structural modifications. Anti Cancer Drug Design 13, 47-66.
6. Chalmers, D.K. & Marshall, G.R. (1995) Pro-D-NMe-Amino Acid and D-Pro- NMe-amino acid: simple, efficient reverse-turn constraints. J. Am. Chem. Soc. 117, 5927-5937.
7. Skchan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.R., Bokesch, H., Kenney, S. & Boyd, M.R. (1990) New colorimetric cytotoxicity assay for anticancer drug screening. J. Natl Cancer Inst. 82, 1107-1112.
8. Frérot, E., Coste, J., Pantaloni, A., Dufour, M.-N. & Jouin, P. (1991) PyBOP and PyBroP: two reagents for the difficult coupling of the α,α-dialkyl amino acid, Aib. Tetrahedron 47, 259-270.
9. Castro, B., Dormoy, J.R., Evin, G. & Selve, C. (1975) Reactifs de douplage peptidique IV (1)-l'hexaflourophosphate de bezotriazolyl N-oxytrisdimethylamino phosphonium (BOP). Tetrahedron Lett. 14, 1219-1222.
10. Hu, M.-K., Badger, A. & Rich, D.H. (1995) Cyclosporin analogs in the 3,7,8-positions. Substituent effects on PPIase inhibition and immunosuppressive activity are non-additive. J. Med. Chem 38, 4164-4170.
11. Alexander, C.W. & Liotta, D.C. (1996) A diastereoselective synthesis of (2S, 3R, 4S)-2-amino-1-cyclohexyl-6-methylheptane-3,4-diol, the Abbott aminodiol. Tetrahedron Lett. 37, 1961-1964.
12. Yamada, S., Ikota, I., Shioiri, T. & Tachibana, S.J. (1975) Diphenyl phosphorazidate (DPPA) and diethyl phosphorocyanidate (DEPC). Two new reagents for solid-phase peptide synthesis and their application to the synthesis of porcine motilin. J. Am. Chem. Soc. 97, 7174-7175.
13. Alley, M.C., Scudiero, D.A., Monks, A., Hursey, M.L., Czerwinski, M.J., Fine, D.L., Abbott, B.J., Mayo, J.G., Shoemaker, R.H. & Boyd, M.R. (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48, 589-601.